Ocular Therapeutix

$16.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.04 (+6.72%) Today
+$0.08 (+0.48%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell OCUL and other stocks, options, and ETFs commission-free!

About OCUL

Ocular Therapeutix, Inc. Common Stock, also called Ocular Therapeutix, is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA. The listed name for OCUL is Ocular Therapeutix, Inc. Common Stock.

CEO
Antony Mattessich
Employees
161
Headquarters
Bedford, Massachusetts
Founded
2006
Market Cap
1.18B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.07M
High Today
$16.66
Low Today
$15.50
Open Price
$15.51
Volume
1.13M
52 Week High
$16.66
52 Week Low
$3.14

Collections

OCUL Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like